131 related articles for article (PubMed ID: 17721655)
1. Bullous lesions at polyethylene glycol interferon-alpha-2a inoculation site in a hepatitis C virus-infected subject.
Montesu MA; Siddi V; Satta R; Pirodda C; Cottoni F
Acta Derm Venereol; 2007; 87(5):433-4. PubMed ID: 17721655
[No Abstract] [Full Text] [Related]
2. Injection site with generalized rash caused by pegylated interferon alpha 2a injection.
Kawada K; Maeda N; Kobayashi S; Sowa J; Tsuruta D; Kawada N
Dermatology; 2006; 212(1):82-3. PubMed ID: 16319482
[No Abstract] [Full Text] [Related]
3. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
[No Abstract] [Full Text] [Related]
4. Cutaneous necrosis complicating the injection of pegylated interferon alpha-2b in a patient with chronic hepatitis C.
Rosina P; Girolomoni G
Acta Dermatovenerol Croat; 2008; 16(1):35-7. PubMed ID: 18358108
[TBL] [Abstract][Full Text] [Related]
5. Skin necrosis after injection of PEG-interferon alpha2b in an HCV-infected patient.
Sparsa A; Loustaud-Ratti V; Alain S; Liozon E; Bédane C; Vidal E
Acta Derm Venereol; 2004; 84(5):415-6. PubMed ID: 15503367
[No Abstract] [Full Text] [Related]
6. A Post-cure Complication.
Nunes J; Marinho RT; Velosa J
Am J Med; 2010 Mar; 123(3):223-4. PubMed ID: 20193828
[No Abstract] [Full Text] [Related]
7. Pegylated interferon, but not conventional interferon therapy induced severe skin lesions.
Li Z; Ji F; Zheng Y; An J; Peng Z
Ann Hepatol; 2012; 11(4):570-1. PubMed ID: 22700642
[No Abstract] [Full Text] [Related]
8. HLA typing in an IFN-alpha-induced scar sarcoidosis: possible pathogenetic and clinical implications.
Zampino MR; Corazza M; Borghi A; Marzola A; Virgili A
Acta Derm Venereol; 2009 Nov; 89(6):661-2. PubMed ID: 19997710
[No Abstract] [Full Text] [Related]
9. [Antiviral therapy for chronic viral hepatitis B and C].
Iino S
Nihon Rinsho; 2003 Feb; 61 Suppl 2():787-91. PubMed ID: 12722317
[No Abstract] [Full Text] [Related]
10. [Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy].
Domínguez Gozalo A; Hidalgo Correas FJ; García Benayas E; García Díaz B
Farm Hosp; 2015 May; 39(3):186-8. PubMed ID: 26005896
[No Abstract] [Full Text] [Related]
11. [Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a].
Maede Y; Morishita K; Iwamura K; Takayama Y; Tsukada Y; Kishino M; Shimizu T; Matsushima S; Komatsu T; Kasagi Y
Nihon Naika Gakkai Zasshi; 2005 Dec; 94(12):2600-2. PubMed ID: 16419601
[No Abstract] [Full Text] [Related]
12. [Hepatitis C infection. Overweight virus carriers are more difficult to cure].
MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219135
[No Abstract] [Full Text] [Related]
13. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Onyike CU; Bonner JO; Lyketsos CG; Treisman GJ
Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966
[No Abstract] [Full Text] [Related]
14. [Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C].
Son BK; Sohn JH; Kim TY; Park YK; Jeon YC; Han DS
Korean J Hepatol; 2007 Mar; 13(1):103-7. PubMed ID: 17380081
[TBL] [Abstract][Full Text] [Related]
15. [Devices for the safe performance of self-injection of interferon therapy for chronic hepatitis C].
Kurihara T; Mikata R; Yokosuka O
Nihon Rinsho; 2006 Jul; 64(7):1368-73. PubMed ID: 16838658
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].
Lopukhova NL
Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502
[No Abstract] [Full Text] [Related]
17. Acquired factor VIII inhibitor in patients with hepatitis C virus infection and the role of interferon-alpha: a case report.
Schreiber ZA; Bräu N
Am J Hematol; 2005 Dec; 80(4):295-8. PubMed ID: 16315253
[TBL] [Abstract][Full Text] [Related]
18. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus.
Cholongitas E; Samonakis D; Patch D; Senzolo M; Burroughs AK; Quaglia A; Dhillon A
Transplantation; 2006 Feb; 81(3):488-90. PubMed ID: 16477242
[No Abstract] [Full Text] [Related]
19. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
20. Sarcoidosis or foreign-body granulomatous reaction during interferon treatment?
Bitetto D; Fumolo E; Fabris C; Toniutto P
Liver Int; 2010 Aug; 30(7):1083-4; author reply 1084. PubMed ID: 20214737
[No Abstract] [Full Text] [Related]
[Next] [New Search]
